Advanced Search

Respiratory Diseases Stocks List

Symbol Grade Name % Change
GILD C Gilead Sciences, Inc. 0.14
HSKA D Heska Corporation 2.32
VIVO C Meridian Bioscience Inc. -2.68
MRK C Merck & Company, Inc. 1.09
SVRA C Savara, Inc. -4.41
TBPH B Theravance Biopharma, Inc. -3.77
VRNA D Verona Pharma plc -6.16
WINT F Windtree Therapeutics, Inc. -2.85
View As Page of Charts
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
Related Stock Lists: Respiratory Disease Medicine Antibiotic Cystic Fibrosis Animal Health Bacterial Infections Biopharmaceutical Diagnostic Products Infectious Diseases Influenza Medication Pharmaceutical Industry Pharmaceutical Products Allergy Allergy Treatment Amines Angina Animal Health Products Antibiotics Antibodies

Related ETFs - A few ETFs which own one or more of the above listed Respiratory Diseases stocks.

Symbol Grade Name Weight
DWSH F AdvisorShares Dorsey Wright Short ETF 24.73
IEIH D iShares Evolved U.S. Innovative Healthcare ETF 10.83
BIS C ProShares UltraShort Nasdaq Biotechnology 7.58
IBB D iShares Nasdaq Biotechnology Index Fund 7.05
FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.99
View all Respiratory Diseases related ETFs...
Compare ETFs
  • Compare BIS to IBB
  • Compare DWSH to FTXH
  • Compare IEIH to BIS

    • Recent Signals

    Date Stock Signal Type
    2021-04-09 GILD 20 DMA Support Bullish
    2021-04-09 GILD 50 DMA Support Bullish
    2021-04-09 GILD Crossed Above 200 DMA Bullish
    2021-04-09 GILD Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-04-09 HSKA Crossed Above 20 DMA Bullish
    2021-04-09 MRK Bollinger Band Squeeze Range Contraction
    2021-04-09 MRK Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-04-09 MRK Crossed Above 50 DMA Bullish
    2021-04-09 SVRA 20 DMA Support Bullish
    2021-04-09 SVRA NR7 Range Contraction
    2021-04-09 SVRA Narrow Range Bar Range Contraction
    2021-04-09 SVRA 1,2,3 Pullback Bullish Bullish Swing Setup
    2021-04-09 SVRA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-04-09 TBPH Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-04-09 TBPH Bearish Engulfing Bearish
    2021-04-09 TBPH Bollinger Band Squeeze Range Contraction
    2021-04-09 TBPH Upper Bollinger Band Walk Strength
    2021-04-09 TBPH Slingshot Bullish Bullish Swing Setup
    2021-04-09 VIVO 50 DMA Support Bullish
    2021-04-09 VIVO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-04-09 VIVO Fell Below 20 DMA Bearish
    2021-04-09 VIVO Stochastic Reached Oversold Weakness
    2021-04-09 VRNA Fell Below 50 DMA Bearish
    2021-04-09 VRNA Stochastic Sell Signal Bearish
    2021-04-09 WINT Stochastic Reached Oversold Weakness

    Recent News for Respiratory Diseases Stocks

    Date Stock Title
    Apr 10 MRK 6 Pet Stocks And An ETF For National Pet Day
    Apr 9 VIVO Meridian Bioscience: Good Stock, But Margin Of Safety Required
    Apr 9 WINT 7 Beaten Down Stocks with Significant Insider Buying
    Apr 9 MRK Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’ : Doctor
    Apr 9 GILD Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’: Doctor
    Apr 9 MRK Sanofi confirms partial response for cancer therapy in mid-stage study
    Apr 9 SVRA 7 Penny Stocks With Interesting Catalysts
    Apr 9 MRK Merck (MRK) Keytruda Meets Endpoint in Kidney Cancer Study
    Apr 9 MRK Organon Announces Pricing of Senior Notes Offering
    Apr 8 GILD Biotech Stocks Could Use A Win — Will The First Quarter Offer That?
    Apr 8 MRK Study shows wearables could detect COVID-19 earlier
    Apr 8 GILD Study shows wearables could detect COVID-19 earlier
    Apr 8 MRK Merck & Co. Is Flatlined But Watch For Its Revival
    Apr 8 MRK Merck’s Keytruda succeeds in late-stage trial as monotherapy in kidney cancer
    Apr 8 GILD COVID-19 vaccinations are ‘extraordinarily safe’: Doctor
    Apr 8 GILD Gilead (GILD) Gets Full Approval for Breast Cancer Drug Trodelvy
    Apr 8 MRK Merck's Keytruda Shows Better Disease-Free Survival As Adjuvant Therapy In Kidney Cancer
    Apr 8 GILD The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
    Apr 8 HSKA Heska First Quarter 2021 Financial Results and Earnings Call Scheduled for May 6, 2021
    Apr 8 GILD Gilead wins full FDA approval for Trodelvy in triple-negative breast cancer
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Respiratory Disease Medicine Antibiotic Cystic Fibrosis Animal Health Bacterial Infections Biopharmaceutical Diagnostic Products Infectious Diseases Influenza Medication Pharmaceutical Industry Pharmaceutical Products Allergy Allergy Treatment Amines Angina Animal Health Products Antibiotics Antibodies

    Browse All Tags